Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

HUHUTECH Surpasses RMB 13.1 Million in Cumulative Project Awards from BYD-Affiliated Facilities Since 2022

HUHUTECH Surpasses RMB 13.1 Million in Cumulative Project Awards from BYD-Affiliated Facilities Since 2022

HUHUTECH International Group Inc. has announced that since 2022, it has been awarded cumulative contracts exceeding RMB 13.1 million (approximately US$1.83 million) by BYD-affiliated manufacturing sites. The projects cover gas detection, monitoring, and facility management systems for advanced manufacturing facilities linked to the new energy vehic…

Inspired Entertainment Launches NBA Re-Play Virtual Sports in Turkey

Inspired Entertainment Launches NBA Re-Play Virtual Sports in Turkey

Inspired Entertainment announced the launch of its NBA Re-Play Virtual Sports game in Turkey, distributed via Sisal Şans and several Electronic Platform Dealers. Featuring all 30 NBA teams and licensed by the NBA and NBPA, the fast-paced virtual basketball game offers a new engaging betting experience to Turkish fans and strengthens Inspired's glob…

Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms

Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms

Syntec Optics, traded on Nasdaq under the ticker OPTX, announced it has received nearly $4 million in new U.S. life sciences purchase orders, adding to previous $4.6 million in biomedical optics orders. The company's high-precision optical products support a broad range of applications in surgical robotics, DNA sequencing, biomedical visualization,…

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds

InterCure Ltd., listed on NASDAQ and TASE, announced a private placement financing raising NIS 22 million (~US$7.4 million) with potential to increase to NIS 54 million (~US$18.6 million). Key investors include CEO Alexander Rabinovich and leading pharma-focused hedge funds such as Bennu Pharma Fund. The funds will support expansion of InterCure's …

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical Holding Corporation announced its CEO will present at the upcoming Virtual Investor Summit, discussing its innovative FDA-approved and breakthrough-designated therapies for acute kidney injury (AKI) in critically ill patients. The company is advancing clinical trials for its Selective Cytopheretic Device (SCD) therapy targeting urge…

Patriot Bank Expands into Palm Beach and the South Florida Market

Patriot Bank Expands into Palm Beach and the South Florida Market

Patriot Bank, a subsidiary of Patriot National Bancorp, is launching a new flagship branch in Palm Beach, Florida, aiming to serve high-net-worth individuals and businesses with personalized banking and lending solutions. Led by experienced market executives Jamie Bruneau and James Ford, the expansion enhances the bank's presence in key wealth cent…

NeoVolta Confirms FEOC Compliance at Georgia Manufacturing Facility; Commissioning on Track for End of August

NeoVolta Confirms FEOC Compliance at Georgia Manufacturing Facility; Commissioning on Track for End of August

NeoVolta Inc. announced that its Pendergrass, Georgia battery manufacturing facility complies with Foreign Entity of Concern (FEOC) requirements, making it eligible for IRS advanced manufacturing and investment tax credits. Site Acceptance Testing is scheduled to complete by August 2026, with production ramp-up expected in Q3 2026. This compliance …

Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification

Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification

Eos Energy Enterprises announced that its Z3 battery modules passed independent destructive fire testing with no thermal runaway, sustained fire, or propagation, meeting new NFPA 855 safety standards for large-scale energy storage. The company also received ISO 14001 certification, underscoring its commitment to environmental management. These resu…

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

FibroBiologics announced that the USPTO issued a Notice of Allowance for their patent application covering methods of treating wounds using topical 3D spheroid fibroblasts and fibroblast-derived materials. This patent supports their lead clinical program, CYWC628, being evaluated for diabetic foot ulcers, a challenging chronic wound.

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Entera Bio announced positive feedback from the FDA on its Phase 3 study protocol for EB613, the first oral anabolic tablet for treating osteoporosis in postmenopausal women. The Phase 3 trial, planned to start in late 2026 with topline data expected in late 2028, will evaluate EB613's efficacy in improving total hip bone mineral density. The NDA s…

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

NewGenIVF Group Limited has issued 3,666,667 new shares to acquire a 10% stake in AI-focused K25.ai, raising its total shares to over 10 million and increasing market capitalization to $7.6 million. This capital boost supports NewGen's strategic pivot towards AI, digital platforms, and prediction markets in APAC, backed by a $10 million investment …

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Vivos Therapeutics, Inc., a NASDAQ-listed medical device company specializing in sleep apnea treatments, has extended its financing agreement timeframe with Streeterville Capital to August 31, 2026. This extension allows the company more time to raise equity in an organized manner and for Streeterville to convert up to $4.5 million of outstanding d…

Kingstone Appoints Sylvie Widjaja to Lead California Business

Kingstone Appoints Sylvie Widjaja to Lead California Business

Kingstone Companies, Inc. announced the appointment of Sylvie Widjaja as Vice President, California Business Leader, to spearhead the company's entry into the California homeowners insurance market on an excess and surplus lines basis. Widjaja brings over 20 years of California market experience, including leadership roles at Mercury Insurance Grou…

Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call

Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call

Saratoga Investment Corp., a business development company specializing in customized financing for U.S. middle-market businesses, will release its fiscal first quarter 2027 financial results on July 7, 2026, with a follow-up conference call scheduled for July 8, 2026. The company focuses on senior and unitranche leveraged loans, mezzanine debt, and…

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Nexentis Technologies' wholly owned subsidiary, MitoCareX Bio, has entered a strategic partnership with AI research lab Boltz to combine their proprietary MITOLINE® structural modeling with Boltz's biomolecular AI models. This collaboration aims to accelerate the discovery of novel small-molecule therapies targeting solute carrier (SLC) proteins re…

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Clearmind Medicine has announced the completion of treatment for all participants in the initial phase (Part A) of its ongoing FDA-regulated Phase I/II clinical trial evaluating CMND-100, a novel therapeutic for Alcohol Use Disorder. The company is analyzing data and plans to proceed to the next stage of clinical development, advancing its non-hall…